Telo Genomics Corp. (TSX-V: TELO) (the “Company” or “TELO”) announces that it has granted incentive stock options to various directors, officers, employees and consultants of the Company to purchase up to an aggregate of 2,100,000 common shares of the Company pursuant to the Company’s stock option plan. The stock options are exercisable at a price of $0.15 per share for a period of five years. The stock option grant is subject to TSX Venture Exchange approval.

For further information, please contact:

Hugh RogersChairman416-673-8487info@telodx.comMaRS Centre, South Tower, 101 College Street, Suite 200, Toronto, ON, M5G 1L7www.telodx.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as such term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Telo Genomics (TSXV:TELO)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024 Plus de graphiques de la Bourse Telo Genomics
Telo Genomics (TSXV:TELO)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024 Plus de graphiques de la Bourse Telo Genomics